Cargando…
Melatonin and (−)-Epigallocatechin-3-Gallate: Partners in Fighting Cancer
We have demonstrated previously that melatonin attenuates hepatotoxicity triggered by high doses of (−)-epigallocatechin-3-gallate (EGCG) in mice. The current work investigated the influence of melatonin on the oncostatic activity of EGCG in two cancer cell lines, wherein melatonin induced an opposi...
Autores principales: | Zhang, Lingyun, He, Yufeng, Wu, Ximing, Zhao, Guangshan, Zhang, Ke, Yang, Chung S., Reiter, Russel J., Zhang, Jinsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678710/ https://www.ncbi.nlm.nih.gov/pubmed/31331008 http://dx.doi.org/10.3390/cells8070745 |
Ejemplares similares
-
A mouse model of subacute liver failure with ascites induced by step-wise increased doses of (-)-epigallocatechin-3-gallate
por: Wang, Xiaoxiao, et al.
Publicado: (2019) -
Epigallocatechin-3-gallate and Epigallocatechin-3-O-(3-O-methyl)-gallate Enhance the Bonding Stability of an Etch-and-Rinse Adhesive to Dentin
por: Yu, Hao-Han, et al.
Publicado: (2017) -
Antioxidant and Pro-Oxidant Activities of Melatonin in the Presence of Copper and Polyphenols In Vitro and In Vivo
por: Wang, Jiajia, et al.
Publicado: (2019) -
Role of Epigallocatechin Gallate in Glucose, Lipid, and Protein Metabolism and L-Theanine in the Metabolism-Regulatory Effects of Epigallocatechin Gallate
por: Lin, Ling, et al.
Publicado: (2021) -
Inhibitory Effects of (−)-Epigallocatechin-3-gallate on Esophageal Cancer
por: Wang, Liu-Xiang, et al.
Publicado: (2019)